The specificity of PD-L1 regulation by resveratrol or piceatannol was further tested using a panel of prostate cancer (PC3, DU145, LNCaP and 22Rv1) and melanoma (RPMI7951, SKMEL28, SKMEL5 and HT144) cell lines (Table 2). This evidence concerns the gene CD274 and prostate cancer.